Anybody got the inside info on the latest top 20 - / isn’t it an obligation ? This mob is the worst on announcements ( there are bigger games at play & they definitely don’t give a rats about retail investors in Australia ) there biggest efforts on information & presentation was at its peak doin a CR everything else has been smoke and mirrors - I believe the conjunction of Psoriasis & Acne is smart as they are of similar cause ( Atopic Dermatitis was a reach - anything of effect on the market is only a few steps away from being more harmful than good and that is not what I believe the properties of CBD strengths ) learning from Acne and applying to Psoriasis and then in turn learning from that applying to both stage 3 trails on both, the cost and time of doin this in this environment would take ages & empty our bank account, by going with Antibacterial ( which I believe are natural properties CBD ) will not only open up a few markets but will restore faith in the brand & loosen up the purse strings to proceed with 1503 & 1308 without a CR
In short Antibacterial in all its different forms ( and there’s many ) will be the springboard for having multiple products with an excellent safety profile
About this insider & leaky ship crap - seriously a 17% increase on a stock which is priced around 5c pre announcement with the chances of not being an bad announcement - the trip up was the time frame and ambiguity - Antibacterial doesn’t have to be the next biggest thing in Antibiotics - the range of products ( both prescribed and not ) and safety profile which will reinforce 1503 & 1308 will do us just fine.
if BOT jumped or climbed swiftly to 10 + on no news I would still say we are undervalued
- Forums
- ASX - By Stock
- No news but up 10%
Anybody got the inside info on the latest top 20 - / isn’t it an...
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
40.0¢ |
Change
0.050(14.3%) |
Mkt cap ! $724.0M |
Open | High | Low | Value | Volume |
35.5¢ | 40.0¢ | 35.5¢ | $6.075M | 15.87M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 287187 | 39.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.0¢ | 1920397 | 33 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 287187 | 0.395 |
1 | 200000 | 0.385 |
8 | 750874 | 0.380 |
2 | 519612 | 0.375 |
5 | 213742 | 0.370 |
Price($) | Vol. | No. |
---|---|---|
0.400 | 1920397 | 33 |
0.405 | 180415 | 6 |
0.410 | 136081 | 11 |
0.415 | 100000 | 1 |
0.420 | 1137203 | 7 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online